Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;12(2):164-72.
doi: 10.1093/neuonc/nop019. Epub 2009 Dec 21.

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma

Affiliations

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma

Wenting Wu et al. Neuro Oncol. 2010 Feb.

Abstract

The purpose of this study is to determine prognostic factors in patients with high-grade recurrent glioma for 3 outcome variables (overall survival, progression-free survival [PFS], and PFS rate 6 months after study registration [PFS6]). Data from 15 North Central Cancer Treatment Group (NCCTG) trials (n = 469, 1980-2004) and 12 North American Brain Tumor Consortium (NABTC) trials (n = 596, 1998-2002) were included. Eighteen prognostic variables were considered including type of treatment center (community/academic) and initial low-grade histology (yes/no). Recursive partitioning analysis (RPA), Cox proportional hazards, and logistic regression models with bootstrap resampling were used to identify prognostic variables. Longer survival was associated with last known grade (Grade) of III, younger age, ECOG performance score (PS) of 0, shorter time from initial diagnosis (DxTime), and no baseline steroid use. Factors associated with longer PFS were Grade III and shorter DxTime. For patients without temozolomide as part of the treatment regimen, the only factor associated with better PFS6 was Grade III, although DxTime was important in RPA and PS was important in logistic regression. Grade was the most important prognostic factor for all three endpoints regardless of the statistical method used. Other important variables for one or more endpoints included age, PS, and DxTime. Neither type of treatment center nor initial low-grade histology was identified as a major predictor for any endpoint.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Wong ET, Kenneth RH, Gleason MJ, et al. Outcome and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol. 1999;17:2572–2578. - PubMed
    1. Carson KA, Grossman SA, Fisher JD, et al. Prognostic factors for survival in adult patients with recurrent gloima enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol. 2007;25:2601–2606. - PMC - PubMed
    1. Breiman L, Friedman RA, Stone CJ. Classification and Regression Trees. Belmont, CA: Wadsworth; 1983.
    1. Therneau TM, Atkinson EJ. Rochester, MN: Department of Health Science Research, Mayo Clinic; 1997. Technical Report Series No. 61. An introduction to recursive partitioning using the RPART routines.
    1. Wiencke JK, Aldape K, McMillan A, et al. Molecular features of adult glioma associated with patient race/ethnicity, age and a polymorphism in O6-methlyguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev. 2005;14:1774–1783. - PubMed

Publication types